Dapivirine Vaginal Ring: Phase III data

Top-line data from the double-blind, South African and Ugandan Phase III Ring Study in 1,959 HIV-negative women ages 18-45 showed that a once-monthly vaginal ring containing 25 mg dapivirine reduced t...